Indefinite Delivery Contract HHSN268201200013I
Award Date
9/21/12
Last Date to Order
9/23/15
Federal Agency
National Heart Lung and Blood Institute
Awardee
Cellectis Bioresearch Inc.
Ultimate Awardee
Not listed
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV is an Indefinite Delivery Contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Xcell Science Incorporated, a woman-owned small business. The contract has a ceiling value of $3,609,000.00 and is a delivery order under the "Gene Insertion - Pluripotent Stem Cells 2012-2017" IDIQ contract. The contract is for SUPPORT- PROFESSIONAL: OTHER services, with a current task order valued at $1,001,068.00 and a completion date of...
The National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, awarded an Indefinite Delivery Contract (IDC) to the New York Stem Cell Foundation, Inc., a non-profit organization, for $6,984,000. The contract supports professional services related to pluripotent stem cell research, with a period of performance from September 21, 2012 to September 23, 2015. Under this multiple-award IDC, the New York Stem Cell Foundation has generated...
This indefinite delivery contract was awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of induced pluripotent stem cell (iPSC)-derived human cell products. The contract supports the supply of a wide range of specialized cell types derived from iPSCs, such as cardiomyocytes, neurons, astrocytes, hepatocytes, and macrophages. These cell...
This indefinite delivery contract was awarded by the National Heart Lung and Blood Institute, a civilian agency of the U.S. federal government, to the prime contractor Applied Biosystems, LLC, a subsidiary of Life Technologies Corporation. The contract, valued at a ceiling of $222,903.87, is for the delivery of laboratory equipment and supplies to support the agency's specialized research and healthcare mission. The award leverages Applied Biosystems' expertise as a manufacturer of genetic...
This Indefinite Delivery Contract (IDC) was awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the Department of Health and Human Services (HHS), to Social & Scientific Systems, Inc., a subsidiary of DLH Holdings Corp. The contract, valued at $13.3 million, supports the Gene Therapy Resource Program (GTRP) by providing resources and services from three core laboratories: a Pharmacology and Toxicology Core Laboratory, a Preclinical Vector Core...
The National Heart, Lung and Blood Institute, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a blanket purchase agreement to Medical Science & Computing, LLC. The IDV provides a contracting vehicle for the agency to obtain professional, scientific, and administrative support services through task order awards against the prime contractor's Multiple Award Schedule contract. Relevant task order awards under the IDV total...
This indefinite delivery contract was awarded by the National Institute on Drug Abuse, a civilian agency of the U.S. federal government, to the Coriell Institute for Medical Research, Inc., a non-profit biomedical research center. The contract, valued at up to $8,561,066.85, is for the development and maintenance of an aged cell bank to support research and development activities. Coriell Institute, a leading provider of biorepository and biospecimen services to the federal government, will be...
This Blanket Purchase Agreement (BPA) was awarded by the National Institutes of Health (NIH) Office of Logistics and Acquisition Operations to Stemcell Technologies Inc., a subsidiary of the Canadian biotechnology company Stemcell Technologies. The BPA has a ceiling value of $10,000,000 and runs through December 31, 2025. Under this single-award IDV, Stemcell Technologies Inc. will provide a comprehensive range of biological materials, blood and blood products, laboratory supplies, media, and...
The provided information describes an Indefinite Delivery Contract (IDC) awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency of the U.S. government. The contract was awarded to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods specializing in biopharmaceutical research and development. The IDC, valued at a ceiling of $48,882,666, covers a broad range of pharmacology studies, animal model development, and...
This is a single-award Indefinite Delivery Contract (IDC) issued by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a contract research and manufacturing organization. The base contract has a potential value of $124,500,000 and a period of performance through September 28, 2028. The purpose is to provide NIAID Preclinical Development Support...